| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.22 | 8e-06 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-05 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.003 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.004 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.094 | 0.006 |